• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ligand Pharm (NQ: LGND )

    80.54 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 80.54
    Bid (Size) 32.22 (2)
    Ask (Size) 128.05 (1)
    Prev. Close 80.54
    Today's Range 80.54 - 80.54
    52wk Range 49.24 - 94.57
    Shares Outstanding 16,676,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand to Participate in Upcoming Investor Conferences
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire

    Performance

    YTD
    +11.38%
    +11.38%
    1 Month
    -7.03%
    -7.03%
    3 Month
    +10.16%
    +10.16%
    6 Month
    +16.17%
    +16.17%
    1 Year
    +4.20%
    +4.20%

    More News

    Read More
    3 Magnificent Growth Stocks to Buy Hand Over Fist
    Via The Motley Fool
    Topics Economy
    Exposures Interest Rates
    3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
    Via InvestorPlace
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Ligand Pharmaceuticals's Earnings: A Preview
    Via Benzinga
    LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Ligand Reports First Quarter 2024 Financial Results
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Don't Overlook These Top Medical Stocks As Q1 Earnings Approach
    Via Talk Markets
    Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    7 Small-Cap Stocks for the Thinking Speculator
    Via InvestorPlace
    Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
    Via Benzinga
    Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Making Surprising Moves in Tuesday Session
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
    From Ligand Pharmaceuticals Incorporated
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.